Morgellon’s Syndrome – Evidence of a Microorganism Causing an Unexplained Dermopathy – Full Text

Follow us on social media


There are thousands of people diagnosed with delusional parasitosis by physicians.
The treatment involves an antipsychotic medication with many serious adverse
effects some of them potentially fatal. Many of the people affl icted with this disease reject the diagnosis believing that their symptoms are caused by an as of yet unidentifi ed microorganism.

The book proposes that perhaps there is more to the pathophysiology of persons
diagnosed with delusional parasitosis than delusions brought on by mental illness
and stimulant drug use. It shows several phenomena that constitute evidence that
there is microorganism that may be responsible for many cases of unexplained

The book is accompanied by a DVD containing all of the photographs and
videos referred to in the book. The reader is encouraged to download the DVD and
use photograph and video software to magnify the photographs and to perform
their own frame by frame analysis of the videos. I used the Sony Picture Utility software provided with my camera.

It is hoped that some more definitive research is performed using the information presented in my book. I performed my investigation on my own
dime with nothing but a camera, a microscope and dogged determination.

The importance of investigating the cause of unexplained dermopathies by a well-
funded institution is clear – the diagnosis of having a mental illness is one of the
hardest diagnoses to live with and especially unjust if it is wrong.

David Conroy

Download link

Related Articles

The HPV Vaccine: An Ethical Dilemma

In 2014 there were numerous reports of mass hysteria and mystery illnesses spreading around the small town of El Carmen De Bolivar, Colombia. According to an article published by CBS, there was a steady increase of young women being hospitalized in this small town, all of which reported the same symptoms of fainting, numbness and tingling of the hands and feet, and headaches. Speculations about the Gardasil vaccination arose, but were disregarded by the mayor of the town stating that “there is no evidence the vaccine, which has undergone extensive testing and regulation is to blame” (CBS, 2014). According to this statement, he is not necessarily wrong, because the clinical trials of this vaccine have been proven to have misleading conclusions due to errors in the study design.

COVID Reference

Six weeks after the third edition, the world has changed again.
The pandemic is raging in South America, particularly in Brazil,
Ecuador and Peru. SARS-CoV-2 is under control in China, but in
Iran it is not. And in Europe, where most countries have weathered
the first wave and open borders to save a compromised tourist season, is now wondering if and for how long this biological
drôle de guerre could last.

Science has moved ahead, too. We have seen a more complex
picture of COVID-19 and new clinical syndromes; the first data
from vaccine trials; first results from randomized controlled
drug studies; encouraging publications on monoclonal neutralizing antibodies and serological evidence about the number of people who have come into contact with SARS-CoV-2. Unfortunately, we have also seen the first science scandal with fake data published in highly ranked journals. And we face new challenges like long-term effects of COVID-19 and a Kawasaki-like inflammatory multisystem syndrome in children.

For quite some time, prevention will continue to be the primary
pillar of pandemic control. In future waves of the SARS-CoV-2
pandemic, we will focus on the conditions under which SARSCoV-
2 is best transmitted: crowded, closed (and noisy) places and
spaces. Although hospitals are not noisy, they are crowded and
closed, and the battle against the new coronavirus will be decided
at the very center of our healthcare system. Over the next
months and maybe years, one of all of our top priorities will be
to give all healthcare workers and patients perfect personal protective equipment.

Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial

Despite our small number of cases, the potential of HCQ in the treatment of COVID-19 has been partially confirmed. Considering that there is no better option at present, it is a promising practice to apply HCQ to COVID-19 under reasonable management. However, Large-scale clinical and basic research is still needed to clarify its specific mechanism and to continuously optimize the treatment plan.

Deleterious Effects of Vaccines – 100s of resources

How can evidence be ignored?…